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Abstract
Micro (mi)RNAs are small non-coding RNAs that regulate the expression of their targets’ messenger RNAs through both
translational inhibition and regulation of target RNA stability. Recently, a number of viruses, particularly of the herpesvirus
family, have been shown to express their own miRNAs to control both viral and cellular transcripts. Although some targets
of viral miRNAs are known, their function in a physiologically relevant infection remains to be elucidated. As such, no in vivo
phenotype of a viral miRNA knock-out mutant has been described so far. Here, we report on the first functional phenotype
of a miRNA knock-out virus in vivo. During subacute infection of a mutant mouse cytomegalovirus lacking two viral miRNAs,
virus production is selectively reduced in salivary glands, an organ essential for virus persistence and horizontal
transmission. This phenotype depends on several parameters including viral load and mouse genetic background, and is
abolished by combined but not single depletion of natural killer (NK) and CD4
+ T cells. Together, our results point towards a
miRNA-based immunoevasion mechanism important for long-term virus persistence.
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Introduction
The human cytomegalovirus (HCMV), a member of the b-
herpesvirus family, is an important pathogen in immunocompro-
mised patients and the leading cause of congenital birth defects
with about 1/1,000 newborns affected [1]. After primary infection,
herpesviruses establish a life-long latent infection, leaving the
infected host at risk of subsequent reactivation and disease. During
their co-evolution with their hosts, cytomegaloviruses have
encountered a broad array of immune defense mechanisms, and
have thus developed multiple strategies to counteract them
(reviewed in [2]). Recently, both viral and cellular miRNAs have
been identified as new players in the complex interaction between
viruses and their hosts, providing interesting new candidates for
targets of urgently needed antiviral drugs (for review see [3]).
These small, ,22 nucleotides long non-coding RNAs regulate the
expression of their targets through both translational inhibition
and regulation of target RNA stability (for review see [4]). While a
single miRNA can regulate the expression of a large number of
target genes, the extent of regulation of protein levels usually does
not exceed two to three fold [5,6]. Although a number of viruses
(particularly of the herpesvirus family) have been shown to express
miRNAs during productive infection and latency [3], the function
of viral miRNAs in a physiologically relevant infection remains to
be elucidated. Sullivan et al. showed that a miRNA mutant murine
polyomavirus was not impaired during in vivo infection [7], and
thus no phenotype of a viral miRNA knock-out mutant has been
described so far. Here, we report on the first functional phenotype
of a mouse cytomegalovirus (MCMV) lacking two miRNAs.
During subacute infection, miRNA mutant virus production was
selectively reduced in salivary glands, the major source of
persistent CMV infection and virus spread from host-to-host
[8,9]. This phenotype depended on several parameters including
viral load and mouse genetic background, and was abolished by
combined depletion of natural killer (NK) and CD4
+ T cells.
Together, our results point towards a miRNA-based immunoeva-
sion mechanism in an organ essential for long-term virus
persistence and host-to-host transmission.
Results/Discussion
Generation of mutant viruses
During productive lytic infection a variety of virally encoded
miRNAs are expressed by both HCMV (11 miRNAs) and MCMV
(18 miRNAs), which accumulate to high levels throughout the
course of infection [10,11,12,13]. This was seen for a number of
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MCMV infected fibroblasts, viral miRNAs constitute as much as
two thirds of the total miRNA pool at three days post infection
(dpi) as assessed by small RNA cloning [12]. At this time-point,
two viral miRNAs, namely miR-M23-2 and miR-m21-1, together
constituted ,25% of the overall miRNAs in small RNA libraries.
Both miRNAs belong to the m21/m22/M23 miRNA cluster and
consist of two pairs of pre-miRNAs, which are expressed antisense
to each other at the same genomic locus (Fig. 1A). Of note, this
peculiar localization does not hinder their relative expression. We
recently reported on an MCMV knock-out mutant lacking both of
these viral miRNAs [11]. In this mutant (DmiR-M23-2), pre-miR-
M23-2 was replaced by 276 nt of stuffer DNA resulting in the
knock-out of both miR-M23-2 and miR-m21-1. We now
constructed a second independent mutant (miR-M23-2-mut) by
traceless mutagenesis [14] inserting 17 point mutations into the
miRNA precursor sequence to disrupt hairpin formation and pre-
miRNA processing (Fig. 1A). In addition, revertants were created
for both viruses (DmiR-M23-2-rev and miR-M23-2-mut-rev) by
fully restoring the native pre-miRNA locus. Expression of the
respective miRNAs was measured by northern blot (Fig. 1B),
confirming efficient knock-out and repair of miRNA expression in
the mutant and revertant viruses, respectively. Expression of the
neighboring genes and miRNAs of the m21/m22/M23 miRNA
cluster were quantified by qPCR (for m21 and M23 mRNAs) (Fig.
S1A, B) and northern blot (for mcmv-miR-M23-1-3p and miR-
m22-1) (Fig. S1C). In both mutants and their respective revertants,
no significant effect on expression levels of neighboring transcripts
or miRNAs was observed. To demonstrate that miR-M23-2 is
functional and can repress luciferase activity of a sensor target
during lytic MCMV infection, we created a reporter construct
expressing firefly luciferase containing a perfect match binding site
for miR-M23-2 in its 39UTR. Dual luciferase assays demonstrated
that miR-M23-2 is functional and can repress luciferase activity of
a sensor target during lytic MCMV infection with wild type (wt)
MCMV and the revertant virus, but not with miR-M23-2-mut
mutant virus (Fig. 1C).
Both MCMV-DmiR-M23-2 and MCMV-miR-M23-2-mut are
specifically attenuated in salivary glands during subacute
infection
Neither of the two miRNA knock-out mutants showed any
attenuation on murine embryonic fibroblasts in vitro ([11] and data
not shown) indicating that the effect of miR-M23-2 mutation on
the virus did not affect viral replication in general. It also
confirmed that no second site mutation gravely impaired any
essential genes of the mutant viruses. We thus started to infect
C57BL/6 and BALB/c mice. While C57BL/6 mice are able to
efficiently control acute MCMV infection, BALB/c mice are more
susceptible. This is due to the activating NK cell receptor Ly49H,
Figure 1. Obtention and characterization of miRNA mutant
MCMV. A. Schematic illustration of MCMV miRNAs expressed from the
m21/m22/M23 MCMV miRNA cluster. Open arrows indicate the coding
regions of the m21, m22 and M23 genes. Black arrows indicate pre-
miRNAs and their orientation. The region deleted and replaced with
stuffer DNA in the DmiR-M23-2 mutant MCMV is indicated (light grey
and dotted lines), whereas asterisks indicate the point mutations in the
miR-M23-2-mut mutant. B. Expression levels of miR-M23-2 and miR-
m21-1 in NIH-3T3 fibroblasts infected at an MOI of 10 for 24 and 48 h
with either wild type (wt) MCMV, MCMV-DmiR-M23-2 (D) and its
revertant (rev) or wt MCMV, MCMV-miR-M23-2-mut (mut) and its
corresponding revertant (rev) were determined by northern blot. The
viral miRNA mcmv-miR-m01-4, the cellular miR-16 and the snRNA U6
were used as controls. M, mock. C. MiR-M23-2 is able to repress target
gene expression late in infection. NIH-3T3 cells were infected either
with wt MCMV, MCMV-miR-M23-2-mut or its revertant. 24 hpi cells were
transfected with a dual luciferase reporter construct containing a
perfect match for miR-M23-2 in the 39-UTR of firefly luciferase (FLUC).
Renilla luciferase (RLUC) activity was used as a transfection control.
Luciferase activity was measured at 48 and 72 hpi.
doi:10.1371/journal.ppat.1001150.g001
Author Summary
The recent discovery of miRNAs of viral origin has
dramatically changed our view on virus-host interaction.
Viral miRNAs have been shown to regulate genes of both
cellular and viral origin, contributing to a favorable
environment for the virus. However, the real importance
of virus-encoded miRNAs during infection of their hosts
remains elusive. In this manuscript, we report on the first
functional phenotype of a miRNA knock-out mutant of the
mouse cytomegalovirus in vivo. We show that the mutant
virus is attenuated specifically in the salivary glands of
infected mice, an organ essential for long-term persistence
of the virus and host-to-host spread. Interestingly, this
attenuation revealed a striking dependence on genetic
background of the mice under study. Only combined
depletion of natural killer and T cells abolished the
phenotype. These results indicate that, by regulating the
immune system, viral miRNAs may play an important role
in an efficient persistent infection.
Cytomegalovirus miRNAs Facilitate Persistent Infection
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recognizes the MCMV m157 protein resulting in robust NK cell
activation and enhanced virus control [15,16]. Following three
days of infection with either wt MCMV, DmiR-M23-2 or its
revertant, no difference in virus titers were observed in lungs,
spleen or kidney (Fig. S2). The lack of attenuation in any organ of
both C57BL/6 and BALB/c at 3 dpi indicates that time might be
an important factor to consider when investigating the function of
viral miRNAs. As miRNAs are only able to repress de novo protein
synthesis but have no effect on existing proteins, their effect
depends on the decay of existing proteins unless their targets are
significantly induced upon infection. Relevant levels of most viral
miRNAs are probably not reached before 12 to 24 hours post
infection (hpi), and it might take even longer until they are able to
recruit significant amounts of their target RNAs to RISC
complexes. As first viral progeny are released from infected cells
as early as 24 hpi [17], viral miRNAs probably do not have
sufficient time to regulate the majority of their targets during early
stages of infection.
We therefore studied mice at 14 dpi. At this time, the immune
system already controls the virus in most organs, except in lungs
and salivary glands. Interestingly, infection with both mutants
resulted in an attenuation of ,100-fold in salivary glands of
C57BL/6 mice. However, only minimal attenuation (,2-fold) was
detectable in salivary glands of BALB/c mice (Fig. 2A and B). In
contrast, all five viruses under study replicated to similar titers in
lungs in both strains. The complete lack of any attenuation in
lungs of C57BL/6 mice was surprising, but confirmed that all mice
had been infected with an equal virus load. As this phenotype was
comparable for both mutants and completely lifted by the two
revertants, we can be confident that the knock-out of the two
miRNAs was responsible for the observed attenuation. As a
consequence, only the second set of mutants (MCMV-miR-M23-
2-mut and its revertant) were used in further experiments. The
lack of attenuation of the miRNA knock-out mutants at 3 dpi as
well as the selective attenuation in C57BL/6 but not BALB/c mice
at 14 dpi following intravenous (i.v.) infection, argues for a specific
function of these two MCMV miRNAs in supporting persistent
infection in salivary glands, and against an impairment of virus
spread to this site. A few MCMV genes have been identified to be
specifically required to maintain spread as well as persistent
infection in salivary glands, but their mode of action has remained
questionable [18].
Level of attenuation is dependent on mouse strain and
viral load
In order to test whether the miRNA knock-out mutant would
require more time for attenuation to become apparent in BALB/c
mice, we infected BALB/c mice for 25 days. While at 25 dpi virus
titers in lungs had significantly dropped compared to 14 dpi, virus
titers in salivary glands were very similar to those seen after 14
days. Only a very small, yet significant attenuation by ,2-fold was
observed in salivary glands (Fig. 2C), while no attenuation was
observed in lungs. This clearly less pronounced attenuation of
mutant virus in salivary glands in BALB/c mice could be the
consequence of the inability of the host immune system to
overcome high virus load in this strain, due to the less stringent
innate immune control, as compared to C57BL/6 mice. Indeed,
virus titers observed in salivary glands of BALB/c mice at both 14
and 25 dpi were significantly higher than in C57BL/6 mice. To
test whether viral load in salivary glands had any effect on the
observed phenotype, we repeated the infection of BALB/c mice
with 20-fold less virus. Remarkably, virus dose reduction now
resulted in a significantly greater attenuation (,5 fold) of the
mutant in salivary glands at 14 dpi (Fig. 2C). The attenuation of
the mutant virus could also be seen in BALB/c mice infected
intraperitoneally with 5610
4 PFU (Fig. S3). To further charac-
terize the effects of host genetics on the observed phenotype, we
tested three other mouse strains with different susceptibility to
MCMV infection (CBA/J, DBA/2 and 129/SvJ mice). In
addition, we also included 129/SvJ.IFNcR
2/2 mice [19], which
lack the IFNc receptor and are thus even more susceptible to
MCMV infection than their parental strain. Interestingly, miR-
M23-2-mut was attenuated in salivary glands of all four strains at
14 dpi (Fig. 3). Despite very high viral load, attenuation was also
observed in 129/SvJ.IFNcR
2/2 mice. Therefore, both host
genetics and viral load are contributing factors involved in
attenuation of the miRNA knock-out mutant in salivary glands.
Notably, control of MCMV in salivary glands is completely
different than in any other tissue. The virus counteracts host
defenses in this sentinel organ by means that are still not fully
understood. Virus persistence in salivary gland tissues appears
mainly to reflect the situation in acinar glandular epithelial cells. In
these cells, MCMV replicates to high titers with a distinct
morphogenesis and without causing gross tissue damage [20].
Infectious particles are stored and secreted from large cytoplasmic
vacuoles, orientated towards excretion ducts, filled with high
numbers (,1,000) of virions [21]. Interestingly, for unknown
reasons, virus isolated from salivary glands of naive mice at 14 dpi
is also several fold more virulent than virus coming from any other
organ or from cell culture. This gain in virulence is lost after a
single round of replication in tissue culture [22]. As MCMV
infection in salivary glands results in prolonged production of virus
with only minimal cytopathic effects, viral miRNAs most likely
gain more time to affect target protein levels in this setting. In
contrast, severe tissue damage in lungs caused by prolonged and
uncontrolled MCMV infection is the main cause of death in
animals infected with a lethal dose of MCMV [23]. We speculate
that the lack of attenuation in lungs after 14 and 25 days of
infection may be explained by the dominance of lytic virus
production over virus persistence. However, selective attenuation
of the miRNA knock-out mutant in salivary glands may also reflect
viral miRNAs targeting immune control mechanisms of particular
importance in this organ or miRNA-mediated effects which, in
other organs, are exerted by other viral genes.
Attenuation of MCMV-miR-M23-2-mut in salivary glands
is reverted by combined but not single depletion of NK-
and CD4-T-cells
In salivary glands MCMV infection is almost completely
resistant to immunological control by CD8
+ T cells. Only the
concerted action of CD4
+ T cells and cells with a natural killer
(NK) cell-like phenotype finally results in termination of
productive infection after many weeks or even months of infection
[8,9]. As such, CD4
+ T cell deficient mice establish persistent
infection for many months, which is restricted to salivary gland
[21]. In addition, cytokine signaling is known to play an important
role (reviewed in [18]). How the virus persists for a long time in
salivary glands, in spite of fully primed immune control, remains
an open question. In order to test whether these two MCMV
miRNAs are involved in immunological control in salivary glands,
we depleted both NK and CD4
+ T cells in C57BL/6 mice. While
the mutant virus was attenuated without NK- and T-cells
depletion, combined depletion resulted in significantly higher
virus titers (Fig. 4A). When we performed single depletion
experiments for NK, CD4
+ or CD8
+ T cells in C57BL/6 mice,
the depletion of NK and CD4
+ T cells but not CD8
+ T cells
resulted in a ,100-fold increase in virus titers (Fig. 4B). This is
Cytomegalovirus miRNAs Facilitate Persistent Infection
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+ cells
and NK cells control MCMV infection in salivary glands and
prevent virus spread [8]. However, although depletion of NK cells
or CD4
+ T cells resulted in significant increase in titers of miR-
M23-2-mut, the differences between equally depleted groups of
mice infected with wt MCMV or miR-M23-2-mut-rev still
remained significant.
Salivary glands are a privileged site for prolonged CMV
replication in spite of a fully primed immune response. Virus
excretion in saliva is an important mechanism for host-to-host
transmission of both murine and human cytomegaloviruses [1]. In
mice, salivary glands also represent the first site to produce virus
after reactivation [8]. In fact, MCMV was originally isolated from
a salivary gland of a persistently infected mouse and was named
salivary gland virus of the mouse [24]. Altogether, our results
indicate that at least one of these two MCMV miRNAs supports
persistent MCMV infection in salivary glands. We speculate that
this particular function of viral miRNA has evolved to allow virus
spread to new hosts via saliva. Interestingly, although the knock-
out of both miRNAs resulted only in a very mild attenuation in
BALB/c mice, attenuation was substantially increased by reducing
the dose of infection. Dependence on viral load in BALB/c mice
perhaps implicates cross-talk between infected cells and thus
implies the involvement of cytokines and/or chemokines. The fact
that only combined depletion of NK cells and CD4
+ T cells
abolished the attenuation may also argue for cytokine dependent
attenuation. Attenuation was preserved even in IFNcR
2/2 mice,
indicating that the mechanism is IFNc independent. Upon severe
immunosuppression, infection of connective tissue fibroblasts is
also observed in salivary glands [21]. Therefore, we cannot
exclude that insufficient immunological control following com-
bined depletion of NK and CD4
+ T cells simply masked the
phenotype of viral miRNAs in persistently infected cells due to the
contribution of lytic infection in surrounding cell populations like
stromal fibroblasts.
Prediction of cellular targets of miR-M23-2
In order to get a hint about the possible mechanism behind the
observed phenotype of our mutant virus, we predicted the
potential cellular targets of miR-M23-2 and miR-m21-1 using
the RepTar algorithm [25]. From these predictions, we extracted
all genes relevant to the immune response, and found 166 and 200
Figure 2. Phenotype of miRNA mutant and revertant MCMV in salivary glands and lungs. A. C57BL/6 mice were injected intravenously
(i.v.) with 3610
5 PFU (left panel) or 1610
5 PFU (right panel) of indicated viruses. Virus titers in salivary glands and lungs were determined 14 days post
infection. There were significant differences in virus titers in salivary glands between the groups of mice infected with miR-M23-2-mut and wt MCMV,
miR-M23-2-mut and miR-M23-2-mut-rev, as well as between the groups of mice infected with DmiR-M23-2 and DmiR-M23-2-rev. B. BALB/c mice were
injected i.v. with 3610
5 PFU of indicated viruses. Virus titers in salivary glands and lungs were determined 14 dpi. C. BALB/c mice were injected i.v.
with 2610
5 PFU (left panel) or 1610
4 PFU (right panel) of indicated viruses. Virus titers in salivary glands and lungs were determined 25 days (left
panel) or 14 days (right panel) post infection. There were significant differences in virus titers in salivary glands between the groups of mice infected
with miR-M23-2-mut and wt MCMV, miR-M23-2-mut and miR-M23-2-mut-rev (left panel), as well as between the groups of mice infected with miR-
M23-2-mut and wt MCMV, and miR-M23-2-mut and miR-M23-2-mut-rev (right panel). Titers in organs of individual mice (circles) and median values
(horizontal bars) are shown. DL = detection limit; * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1001150.g002
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(Table S1). Among these predictions, 77 genes were predicted to
be targeted by both miRNAs. The chemokine CXCL16 was
among the top predicted targets with multiple putative binding
sites for both miR-m21-1 and miR-M23-2 (Fig. S4). The predicted
binding of miR-M23-2 was more favorable than that of miR-m21-
1 in terms of free energy of pairing. CXCL16 is a recently
discovered chemokine that is expressed in both soluble and
transmembrane forms, ligates to CXCR6 chemokine receptor and
guides migration of activated Th1 and Tc1 cells [26], as well as
NK cells [27]. It is mainly expressed by dendritic cells and
macrophages, but also by fibroblasts and endothelial and epithelial
cells [28,29]. We cloned the full length 39UTR of CXCL16 in a
luciferase reporter vector, and tested its regulation by both miR-
M23-2, and miR-m21-1. While no measurable regulation was
observed for miR-m21-1, miR-M23-2 readily regulated the
CXCL16 reporter (Fig. S5A). In addition, using 29-O-methylated
antisense oligonucleotide, we confirmed that the CXCL16
reporter regulation by miR-M23-2 could be inhibited in a
sequence specific manner (Fig. S5B). In order to test whether
miR-M23-2 could also regulate the CXCL16 reporter in the
context of virus infection, we transfected the CXCL16 luciferase
reporter in cells infected either with the miR-M23-2-mut virus or
its revertant. The repression of a luciferase reporter containing
either a perfect match sensor, a mismatched sensor for miR-M23-
2 or the 39UTR of CXCL16, was only detectable in cells infected
with the revertant, but not the mutant virus (Fig. S5C).
Both cellular and viral miRNAs are known to target a large
number of different genes. As such, hcmv-miR-UL112-1 targets a
number of viral transcripts including the major viral transactivator
IE1 as well as the host’s NK cell activating ligand MICB
[25,30,31]. Knock-out of both miR-M23-2 and miR-m21-1
probably resulted in the loss of regulation of several genes.
Therefore, although preliminary observations indicate that
CXCL16 is a target of miR-M23-2 but not of miR-m21-1, it is
very unlikely that its regulation is the sole reason for the
attenuation of miR-M23-2/m21-1 mutant viruses. This concept
is also supported by our findings that attenuation of the miR-M23-
2/m21-1 mutant viruses revealed dependence on host genetics and
viral load, indicating a multifactorial rather than a single mode of
regulation. Indeed, our target predictions contained numerous
other genes involved in innate immune response (Table S1).
Although the exact mechanism by which miR-M23-2 and miR-
m21-1 contribute to an efficient accumulation in salivary glands
remains to be identified, we hypothesize that these viral miRNAs
contribute to the generation of a microenvironment in this organ
that is favorable for the virus to persist. Additional mechanisms
such as the regulation of viral gene expression might also
contribute to the observed phenotype. In this context, it is not
surprising that lifting only one type of control, e.g. depletion of
CD4
+ T cells, was not sufficient to completely revert viral miRNA
function.
Viral miRNAs have been implicated in the control of viral
latency and reactivation although formal proof in vivo is still lacking
[3]. Our data not only provide the first in vivo phenotype of viral
miRNAs but also demonstrate that viral miRNAs are important in




All of the protocols used for breeding of mice and different kinds
of treatments were approved by the Ethical Committee of the
Faculty of Medicine University of Rijeka and were performed in
accordance with Croatian Law for the Protection of Laboratory
Animals, which has been harmonized with the existing EU
legislation (EC Directive 86/609/EEC).
Construction of mutant viruses
As pre-miR-M23-2 and pre-miR-m21-1 are located on
opposing strands of the MCMV genome and are 98% comple-
mentary (the predicted 59-end of pre-miR-m21-1 extends the 39-
end of pre-miR-M23-2 by one nucleotide), deletion of one miRNA
always results in concordant knock-out of the other. To exclude
unexpected effects on the genomic locus by the miRNA knock-out
we constructed two independent mutants and revertants. The
generation of the first mutant (MCMV-DmiR-M23-2) has been
described [11]. The revertant virus was created by replacing the
276 bp insert with an expression cassette for galactokinase (GalK)
and kanamycin resistance (Kn) in DH10B E.coli. The linear DNA
fragment was generated by PCR on pGPS-GalK/Kn using
primers H5-miR-M23-2-galK/Kn and H3-miR-M23-2-galk/Kn.
Sequences of these and all other primers are provided in Table S2.
After transferring the recombinant BAC to SW102 bacteria by
electroporation, the wt pre-miR-M23-2 sequence was restored by
traceless mutagenesis using a linear DNA fragment generated by
PCR on pSM3fr using the PCR primers H5-miR-M23-rev and
H3-miR-M23-rev [14]. The second mutant (MCMV-miR-M23-2-
mut) was constructed solely in SW102 bacteria. First, the whole
m21/m22/M23 locus of pSM3fr was replaced using homologous
recombination by a GalK/Kn cassette amplified from pGPS-
GalK/kn using primers H5-GalK/Kn-m22 and H3-GalK/Kn-
m22. Next, the whole m21/m22/M23 miRNA cluster containing
4 miRNAs and part of the m22 gene was subcloned into pGPS1.1
(resulting in pGPS-m22) by PCR cloning using primers m22-for
and m22-rev. To generate the mutant pre-miR-M23-2 template,
17 point mutations were inserted into the pre-miR-M23-2 within
pGPS-m22 (resulting in pGPS-m22-miR-M23-2-mut) by oligonu-
Figure 3. Attenuation of miRNA mutant MCMV in various
mouse genetic backgrounds. C57BL/6, CBA/J, DBA/2, 129/SvJ. and
129/SvJ IFNcR
2/2 mice were i.p. injected with 2610
5 PFU of MCMV-
miR-M23-2-mut or MCMV-miR-M23-2-mut-rev. Virus titers in salivary
glands were determined 14 dpi. Titers in organs of individual mice
(circles) and median values (horizontal bars) are shown. There were
significant differences in virus titers in salivary glands between mice
infected with MCMV-miR-M23-2-mut and MCMV-miR-M23-2-mut-rev for
C57BL/6, CBA/J, DBA/2 and 129.SvJ IFNgR
2/2 mice. DL = detection
limit; * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1001150.g003
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mut-s and pre-miR-M23-2-mut-as and an ApaL1 and PvuI digest.
The m21/m22/M23 locus with the mutated pre-miR-M23-2 was
excised from pGPS-m22-miR-M23-2-mut using EcoRV and
inserted into pSM3fr-m22-galK/Kn by traceless mutagenesis
resulting in the MCMV-M23-2-mut BAC. To generate the
revertant, the GalK/Kn cassette was reinserted again as described
above followed by reinsertion of the wt m21/m22/M23 miRNA
cluster using the EcoRV fragment of pGPS-m22.
All viruses were reconstituted by transfecting the recombinant
BACs into murine embryonic fibroblasts as described [23]. Virus
titers were determined on MEFs by standard plaque assay [23].
Northern blot analysis
RNA was extracted using TRIzol and northern blotting was
performed on 10 mg of total RNA as described before [11,32].
Probes were 59
32P-radiolabelled oligodeoxynucleotides perfectly
complementary to the miRNA sequence or to part of the U6
snRNA sequence. Blots were analyzed and quantified by
phosphorimaging using a FLA5100 scanner from Fuji.
Quantitative PCR analysis of viral transcripts
Real time PCR analysis of m21 and M23 transcripts was
performed as described before [12] using primers m21for and
m21rev and M23for and M23rev respectively as indicated in
Table S2.
Target prediction by RepTar algorithm
RepTar is a miRNA target prediction algorithm that is
independent of evolutionary conservation considerations and is
not limited to seed pairing sites. It is based on the finding that in
some targets the miRNA binding site repeats in the 39UTR. It
Figure 4. Reversion of the miRNA mutant phenotype by immune cells depletion. A. C57BL/6 mice depleted for both NK and CD4
+ T-cells
or mock treated were i.v. injected with 3610
5 PFU of either wt MCMV, MCMV-miR-M23-2-mut or its revertant. Virus titers in salivary glands were
determined 14 dpi. Differences in virus titers were significant between groups of undepleted mice infected with miR-M23-2-mut and wt MCMV, as
well as with miR-M23-2-mut and miR-M23-2-mut-rev. Depletion of CD4
+ T cells and NK cells resulted in significant increase in the titer of miR-M23-2-
mut as well as miR-M23-2-mut-rev. Differences in virus titers between groups of depleted animals infected with miR-M23-2-mut and miR-M23-2-mut-
rev were not significant. The crosses for the group of wt MCMV infected and CD4 and NK cell depleted group indicate animals that died a day before
virus determination. B. C57BL/6 mice, undepleted or depleted of either CD4
+ T cells, CD8
+ T cells or NK-cells, were i.p. injected with 2610
5 PFU of wt
MCMV, MCMV-miR-M23-2-mut or its revertant. Virus titers in salivary glands were determined 14 dpi. Titers in organs of individual mice (circles) and
median values (horizontal bars) are shown. DL = detection limit; * p,0.05; ** p,0.01.
doi:10.1371/journal.ppat.1001150.g004
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them to the miRNA sequences and evaluates them as candidate
miRNA binding sites. Based on the information gained from these
repetitive sites, RepTar then searches for non-repetitive sites as
well. The final set of Reptar predictions includes targets with
conserved or non-conserved single or multiple binding sites of
several types including: seed binding sites, seed wobble sites (seed
sites that include G:U pairing in the seed), 39 compensatory
binding sites and full-match binding sites. The special properties of
the algorithm make it advantageous for predicting targets of the
less conserved viral miRNAs.
Dual luciferase experiments
The perfect match sensor for miR-M23-2 was obtained by
annealing the oligonucleotides PM-M23-2-for and PM-M23-2-
rev. The miR-M23-2 mismatch sensor was obtained by annealing
the oligonucleotides MM-M23-2-for and MM-M23-2-rev. The
39UTR of CXCL16 (position 16–1100) was PCR amplified from
NIH-3T3 genomic DNA using primers CXCL16-for and
CXCL16-rev. To each product, AttB1 and AttB2 sites were
incorporated by PCR using primers AttB1-for and AttB2-rev (see
Table S2). The resulting PCR products were then recombined
sequentially in pDONR/Zeo and in psiCHECK-2 plasmids using
Gateway technology (Invitrogen). NIH-3T3 cells were infected
with wt MCMV, MCMV-miR-M23-2-mut as well as with
MCMV-miR-M23-2-mut-rev at an MOI=10 using centrifugal
enhancement. 24 h post infection cells were transfected with
psiCHECK-PM-M23-2 using the TransIT-3T3 Transfection kit
(Mirus) following the manufacturer’s instructions. At 48 and 72 h
post infection luciferase activities were measured employing the
Dual-Luciferase Reporter Assay (Promega).
For CXCL16 dual luciferase assays, constructs were co-
transfected into NIH-3T3 cells with the indicated concentrations
of miRNA mimic or Allstars negative control siRNA (Qiagen),
using lipofectamine 2000 (Invitrogen) as per manufacturer’s
instructions. Luciferase activities were measured 48 h post
transfection (Glomax, Promega). The inhibition of miRNA activity
was performed by co-transfection of 100 nM 29-O-methylated
oligonucleotides specific for miR-M23-2 or for C. elegans miR-67 as
a control. For CXCL16 luciferase assays in MCMV-infected cells,
NIH-3T3 cells were infected with MCMV-miR-M23-2 mut or
MCMV-miR-M23-2-mut-rev at an MOI=10, using centrifugal
enhancement. 24h post infection cells were transfected with
psiCHECK-PM-M23-2, psiCHECK-MM-M23-2 or psiCHECK-
CXCL16 using lipofectamine 2000 (Invitrogen) as per manufac-









b) and 129/SvJ IFNcR
-/- (H-2
b) mice were
housed and bred under specific-pathogen-free conditions at the
Central Animal Facility, Faculty of Medicine, University of Rijeka.
Infection conditions and detection of infectious MCMV in
tissues, depletion of lymphocyte subsets, and statistical
evaluation
Mice were injected either intraperitoneally or intravenously
with indicated doses (1610
4 PFU to 5610
5 PFU) of tissue culture-
grown wt MCMV or recombinant viruses in 0.5 ml of diluent.
Organs were collected either 14 or 25 days after infection and
virus titers were determined by a standard plaque-forming assay
[33]. In vivo depletion of CD4
+ and CD8
+ T lymphocyte subsets
and NK cells was performed by intraperitoneal injection of the
mAbs to CD4 (YTS191.1), to CD8 (YTS 169.4) molecules [34]
and to NK1.1 (PK136) [35]. Statistical significance of the
difference between experimental groups was determined by the
Mann-Whitney exact rank test.
Supporting Information
Figure S1 Quantitative analysis of miR-M23-2 flanking tran-
scripts and miRNAs. A and B. qRT-PCR analysis of m21 and
M23 transcripts accumulation in wt MCMV, DmiR-M23-2, miR-
M23-2-mut and their revertants infected NIH-3T3 cells at 48 hpi.
Data was normalized to IE1 expression levels. C. Northern blot
analysis of miR-M23-1-3p and miR-m22-1 accumulation in cells
infected with wt MCMV, DmiR-M23-2, miR-M23-2-mut and
their revertant viruses at 48 hpi. M, mock infected cells; EtBr,
Ethidium Bromide.
Found at: doi:10.1371/journal.ppat.1001150.s001 (0.24 MB TIF)
Figure S2 Virus titers of wt MCMV, DmiR-M23-2 and miR-
M23-2-mut in various organs at 3 days post infection. C57BL/6
and BALB/c mice were injected i.v. with 5610
5 or 3610
5 PFU,
respectively with wt MCMV, DmiR-M23-2 and miR-M23-2-mut,
as well as with their respective revertants. Virus titers in organs
were determined 3 days post infection. Titers in organs of
individual mice (circles) and median values (horizontal bars) are
shown. DL = detection limit.
Found at: doi:10.1371/journal.ppat.1001150.s002 (0.12 MB TIF)
Figure S3 Virus titers of wt MCMV, miR-M23-2-mut and miR-
M23-2-mut-rev in BALB/c salivary glands and lungs at 14 days
post intraperitoneal infection. Titers in organs of individual mice
(circles) and median values (horizontal bars) are shown. DL =
detection limit; * p,0.05; ** p,0.01.
Found at: doi:10.1371/journal.ppat.1001150.s003 (0.11 MB TIF)
Figure S4 Schematic representation of miR-M23-2 and miR-
m21-1 binding sites within the CXCL16 39UTR. Shown are the
sites predicted by RepTar version 1.1, based on the statistical
profiles of repeating elements in the 39UTR. The miRNA is
indicated in red on top of the alignment. For miR-M23-2 there is
an additional full seed match at position 221, which was not
detected by the version of the algorithm used at the time of the
analysis. Loc: position in 39UTR (location is zero based). DG: free
energy of pairing in Kcal/mol.
Found at: doi:10.1371/journal.ppat.1001150.s004 (0.31 MB TIF)
Figure S5 Identification of a putative cellular target of miR-
M23-2. A. CXCL16 is regulated by miR-M23-2, but not by miR-
m21-1. NIH-3T3 fibroblasts were co-transfected with a bulged
luciferase sensor for miR-M23-2 or a luciferase reporter construct
containing the entire CXCL16 39UTR, and with the indicated
miRNA oligonucleotides mimics or negative control siRNA. Dual
luciferase assays were performed 48 h post-transfection (n=5).
FLUC to RLUC ratios were first normalized to the values
obtained for the empty reporter vector and then to the values
obtained with the negative control siRNA, which were set to 1. B.
Regulation by miR-M23-2 oligonucleotide mimic of both
mismatched sensor for miR-M23-2 and CXCL16 39UTR
luciferase reporter can be reverted by co-transfection of a 29-O-
methylated (29O Me) antisense oligonucleotide directed against
miR-M23-2, but not by a control (Ctrl) 29-O-methylated antisense
oligonucleotide directed against the C. elegans miRNA miR-67.
Dual luciferase assays were performed 48 h post-transfection
(n=6). FLUC to RLUC ratios were first normalized to the values
obtained for the empty reporter vector and then to the values
obtained with the control 29-O-methylated oligonucleotide, which
Cytomegalovirus miRNAs Facilitate Persistent Infection
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(MM) sensors for miR-M23-2 or CXCL16 39UTR luciferase
reporters in cells infected with MCMV-miR-M23-2-mut or its
corresponding revertant. Dual luciferase assays were performed
48 h post-transfection (n=3). Shown here is a representative
example of four independent experiments.
Found at: doi:10.1371/journal.ppat.1001150.s005 (0.46 MB TIF)
Table S1 Immuno-related predicted targets of miR-m21-1 and
miR-M23-2. Gene annotations were extracted from http://cgap.
nci.nih.gov/Genes/GOBrowser. All genes with the GO Biological
Process category: ‘‘immune system process’’ were considered
immuno-related. For each target gene the number of predicted
binding sites and the binding site with minimal free energy upon
miRNA:39UTR pairing are reported. The minimal free energy
value and the pattern of base-pairing for this site are shown
(computed by the program RNAcofold of Vienna package).
miRNA and mRNA are displayed as the upper and lower string,
respectively. A solid line represents canonical Watson-Crick base
pairing, and a colon represents G:U base pairing.
Found at: doi:10.1371/journal.ppat.1001150.s006 (1.04 MB PDF)
Table S2 List of PCR primers and oligonucleotides.
Found at: doi:10.1371/journal.ppat.1001150.s007 (0.23 MB PDF)
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